Tag: GLP-1 agonist

Clinical trial data showing efficacy of oral GLP-1 medication for type 2 diabetes management
Clinical UpdatesNew StudiesPracticeResearch Digest

Oral GLP-1 medication shows major promise for type 2 diabetes: weight loss and blood sugar control in pivotal trial

A pivotal clinical trial demonstrates that a new oral GLP-1 medication achieves substantial improvements in blood sugar control and weight…

By
GMJ Practice Desk
Medical chart showing HbA1c reduction with GLP-1 receptor agonist therapy in type 2 diabetes patients
Clinical UpdatesNew StudiesPracticeResearch Digest

Orforglipron Shows Clinically Significant HbA1c Reductions in Type 2 Diabetes

Two phase III randomised controlled trials presented at the American Diabetes Association conference in June 2026 demonstrate that orforglipron, a…

By
GMJ Practice Desk
Wegovy oral tablets and injectable pens showing new UK-approved weight loss treatment options
Clinical UpdatesHealth PolicyPolicy & SystemsPractice

UK Approves First Oral GLP-1 Pill for Weight Loss as Wegovy Tablet Gets MHRA Clearance

The UK's MHRA has approved the first oral GLP-1 pill for weight loss, offering a tablet alternative to injectable Wegovy.…

By
GMJ Practice Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →